Drug Profile
Research programme: CFTR inhibitors - Active Pass
Alternative Names: ABC transporter inhibitors research programme - Active Pass; Research programme: polycystic kidney disease therapy - Active Pass; Research programme: seceretory diarrhoea therapy - Active PassLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Active Pass Pharmaceuticals
- Class
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diarrhoea; Polycystic kidney disease
Most Recent Events
- 11 Aug 2005 Preclinical trials in Polycystic kidney disease in Canada (unspecified route)
- 15 Jun 2004 Discontinued - Preclinical for Age-related macular degeneration in Canada (unspecified route)
- 15 Jun 2004 Discontinued - Preclinical for Alzheimer's disease in Canada (unspecified route)